- Home
- NVCR vs USPH Comparison
NVCR vs USPH Comparison
Compare NVCR & USPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVCR | USPH |
|---|---|---|
| Founded | 2000 | 1990 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2015 | 1992 |
Fundamental Metrics
Financial Performance| Metric | NVCR | USPH |
|---|---|---|
| Price | $12.11 | $74.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $28.42 | ★ $108.20 |
| AVG Volume (30 Days) | ★ 1.9M | 194.8K |
| Earning Date | 10-30-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 2.40% |
| EPS Growth | N/A | ★ 153.49 |
| EPS | N/A | ★ 2.38 |
| Revenue | $642,269,000.00 | ★ $750,948,000.00 |
| Revenue This Year | $9.75 | $19.53 |
| Revenue Next Year | $5.62 | $6.33 |
| P/E Ratio | ★ N/A | $31.57 |
| Revenue Growth | 11.17 | ★ 17.51 |
| 52 Week Low | $10.70 | $62.77 |
| 52 Week High | $34.13 | $99.35 |
Technical Indicators
Market Signals| Indicator | NVCR | USPH |
|---|---|---|
| Relative Strength Index (RSI) | 50.47 | 45.86 |
| Support Level | $10.79 | $71.77 |
| Resistance Level | $11.86 | $75.28 |
| Average True Range (ATR) | 0.59 | 2.85 |
| MACD | 0.06 | 0.96 |
| Stochastic Oscillator | 65.00 | 78.15 |
Price Performance
Historical ComparisonAbout NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About USPH U.S. Physical Therapy Inc.
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.